These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 3195602
1. Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19. Deftos LJ, Woloszczuk W, Krisch I, Horvat G, Ulrich W, Neuhold N, Braun O, Reiner A, Srikanta S, Krisch K. Am J Med; 1988 Dec; 85(6):780-4. PubMed ID: 3195602 [Abstract] [Full Text] [Related]
9. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid. Hanna FW, Ardill JE, Johnston CF, Cunningham RT, Curry WJ, Russell CF, Buchanan KD. J Endocrinol; 1997 Feb; 152(2):275-81. PubMed ID: 9071985 [Abstract] [Full Text] [Related]
11. Immunochemical characterization of a novel secretory protein (defined by monoclonal antibody HISL-19) of peptide hormone producing cells which is distinct from chromogranin A, B, and C. Krisch K, Horvat G, Krisch I, Wengler G, Alibeik H, Neuhold N, Ulrich W, Braun O, Hochmeister M. Lab Invest; 1988 Apr; 58(4):411-20. PubMed ID: 2833657 [Abstract] [Full Text] [Related]
12. Chromogranin A as tumor marker in medullary thyroid carcinoma. Blind E, Schmidt-Gayk H, Sinn HP, O'Connor DT, Raue F. Thyroid; 1992 Apr; 2(1):5-10. PubMed ID: 1356053 [Abstract] [Full Text] [Related]
13. Secretogranin IV immunoreactivity in medullary thyroid carcinoma: an immunohistochemical study of 62 cases. Neuhold N, Ullrich R. Virchows Arch A Pathol Anat Histopathol; 1993 Apr; 423(2):85-9. PubMed ID: 7692664 [Abstract] [Full Text] [Related]
14. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions. Komminoth P, Roth J, Saremaslani P, Matias-Guiu X, Wolfe HJ, Heitz PU. Am J Surg Pathol; 1994 Apr; 18(4):399-411. PubMed ID: 8141431 [Abstract] [Full Text] [Related]
15. Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas? Franke WG, Pinkert J, Runge R, Bredow J, Wunderlich G, Koch R. Anticancer Res; 2000 Apr; 20(6D):5257-60. PubMed ID: 11326706 [Abstract] [Full Text] [Related]
16. Significance of chromogranin A and synaptophysin in medullary thyroid carcinoma. Tomita T. Bosn J Basic Med Sci; 2021 Oct 01; 21(5):535-541. PubMed ID: 33485291 [Abstract] [Full Text] [Related]
17. Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma. Seok JY, Kang M, De Peralta-Venturina M, Fan X. Int J Surg Pathol; 2021 Sep 01; 29(6):615-626. PubMed ID: 33650906 [Abstract] [Full Text] [Related]
18. [Medullary thyroid carcinoma. Immunohistochemical markers in histopathology and research]. Schmid KW, Böcker W. Zentralbl Pathol; 1993 Jun 01; 139(2):115-29. PubMed ID: 8369268 [Abstract] [Full Text] [Related]
19. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid. Parmer M, Milan S, Torabi A. Int J Surg Pathol; 2017 Apr 01; 25(2):191-194. PubMed ID: 27658647 [Abstract] [Full Text] [Related]
20. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors. Lloyd RV, Cano M, Rosa P, Hille A, Huttner WB. Am J Pathol; 1988 Feb 01; 130(2):296-304. PubMed ID: 3341449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]